3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Lung Neoplasms
1
Liver Diseases
1
Carcinoma, Hepatocellular
1
Interventions
lenvatinib
2
atezolizumab
2
Bevacizumab
2
Antibodies
2
sintilimab
1
pembrolizumab
1
camrelizumab
1
User-Centered Design
1
Standard of Care
1
Neuropsychological Tests
1
Neoadjuvant Therapy
1
Liver Transplantation
1
Lead
1
Injections
1
Control Groups
1
Catheter Ablation
1
Adjuvants, Pharmaceutic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Liver Diseases
×
Adjuvants, Pharmaceutic
×
Clear all
NCT04727307
2025-09-30
AB-LATE02
University Hospital, Montpellier
Phase 2
Recruiting
202 enrolled